Sinnamon, Andrew J. https://orcid.org/0000-0001-6031-6451
Pimiento, Jose M.
Article History
Received: 3 November 2025
Accepted: 4 November 2025
First Online: 18 November 2025
Disclosures
: Jose Pimiento serves as a consultant for Ferranova, AstraZeneca, and Alcresta. These affiliations are unrelated to the content of this manuscript.